Replies to post #406165 on Amarin Corp Plc (AMRN)

[couldbebetter]

Right now we do not know the status and/or the capabilities of Eddingpharm.
We do not know if they can even meet the milestone payments in the initial
agreement. I expect Denner and his 7 BOD reps are figuring out answers
to all of this. Having or not having Vascepa as a viable product in China
could make a huge difference in AMRN's value to a BP. As Lizzy has pointed
out there are many unanswered questions here.